Founded in 1972, Eurofarma is a Brazilian multinational corporation dedicated to the biopharmaceutical industry. Its core mission is to enhance health and quality of life through innovative pharmaceutical products and services. Eurofarma's diverse portfolio includes prescription drugs, non-prescription medications, generics, hospital products, and oncology treatments. With a strong market presence in Brazil and worldwide, the company is committed to generating shared value and improving healthcare outcomes.
Notable figures associated with Eurofarma include CEO Maurízio Billi. The company has achieved significant milestones, including a revenue of R$ 5.7 billion in 2020 and employing 7,600 people globally. Eurofarma's subsidiaries, such as Magabi Pesquisas e Farmacêutica and Supera Rx Medicamentos, further bolster its market position. The company's impact is evident in its extensive product range and commitment to innovation in biopharmaceuticals, contributing significantly to global healthcare advancements.
